(Q33337433)

25 July 2017

1 reference

title

Hemostatic changes in patients with malignancy (English)

1 reference

25 July 2017

Goldsmith GH

1

1 reference

25 July 2017

publication date

1 February 2001

1 reference

International Journal of Hematology

25 July 2017

published in

1 reference

25 July 2017

volume

73

1 reference

25 July 2017

issue

2

1 reference

25 July 2017

page(s)

151-156

1 reference

Hemostatic Abnormalities in Malignancy, a Prospective Study of One Hundred Eight Patients: Part I. Coagulation Studies

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02981931

The hypercoagulable states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02981931

Neurologic manifestations of intravascular coagulation in patients with cancer: A clinicopathologic analysis of 12 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02981931

Lupus anticoagulant: a clinical and laboratory study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02981931

Coagulopathy in amyloidosis: Combined deficiency of factors IX and X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02981931

Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02981931

Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency

21 January 2018

1 reference

12 December 2020

The pathophysiology and treatment of hemorrhagic syndrome of acute promyelocytic leukemia

1 reference

12 December 2020

Bleeding time and platelet function in essential thrombocythemia and other myeloproliferative syndromes

1 reference

12 December 2020

A case of Hageman factor deficiency with myeloid leukaemia

1 reference

12 December 2020

Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis

1 reference

12 December 2020

Mechanism of factor X deficiency in systemic amyloidosis

1 reference

12 December 2020

Acquired von Willebrand's Syndrome and Thrombopathy in a Patient with Chronic Lymphocytic Leukaemia

1 reference

12 December 2020

A macroglobulin with inhibitory activity against coagulation factor VIII

1 reference

12 December 2020

Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL

1 reference

12 December 2020

Disseminated intravascular coagulation in acute leukemia

1 reference

12 December 2020

Autoimmune thrombocytopenic purpura ("ITP" type) with chronic lymphocytic leukemia.

1 reference

12 December 2020

Acquired von Willebrand's disease in association with Wilm's tumor: regression following treatment

1 reference

12 December 2020

Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia?

1 reference

12 December 2020

Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder

1 reference

12 December 2020

Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer

1 reference

12 December 2020

Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors.

1 reference

12 December 2020

The prethrombotic state in cancer

1 reference

12 December 2020

Recurrent, isolated factor X deficiency in myeloma: repeated normalization of factor X levels after cytostatic chemotherapy followed by late treatment failure associated with the development of systemic amyloidosis

1 reference

12 December 2020

Reassessing the hemostatic disorder associated with acute promyelocytic leukemia

1 reference

12 December 2020

1 reference

12 December 2020

Guidelines for clotting studies in cancer patients. For the Scientific and Standardization Committee of the Subcommittee on Haemostasis and Malignancy International Society of Thrombosis and Haemostasis.

1 reference

12 December 2020

Deep-vein thrombosis and the incidence of subsequent symptomatic cancer

1 reference

12 December 2020

The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.

1 reference

12 December 2020

Acquired type II von Willebrand's disease: demonstration of a complexed inhibitor of the von Willebrand factor-platelet interaction and response to treatment

1 reference

12 December 2020

Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients

1 reference

12 December 2020

Essential thrombocythemia. Clinical characteristics and course of 61 cases

1 reference

12 December 2020

Haemostatic problems in acute leukaemia

1 reference

12 December 2020

Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes

1 reference

12 December 2020

Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia

1 reference

12 December 2020

The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u-PA rather than defibrination

1 reference

12 December 2020

Microangiopathic haemolytic anaemia and mucin-forming adenocarcinoma

1 reference

12 December 2020

Direct evidence for systemic fibrinogenolysis in a patient with metastatic prostatic cancer

1 reference

12 December 2020

The Long-Term Clinical Course of Acute Deep Venous Thrombosis

1 reference

12 December 2020

Pathways of coagulation/fibrinolysis activation in malignancy.

1 reference

12 December 2020

Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies

1 reference

12 December 2020

Activation of blood coagulation in cancer: Trousseau's syndrome revisited.

1 reference

12 December 2020

Hypercoagulability in cancer

1 reference

12 December 2020

Mucin-producing adenocarcinomas and nonbacterial thrombotic endocarditis: pathogenetic role of tumor mucin

1 reference

12 December 2020

Hemostatic abnormalities in untreated cancer: incidence and correlation with thrombotic and hemorrhagic complications

1 reference

12 December 2020

Autoimmune thrombocytopenic purpura

1 reference

12 December 2020

Hemostatic defects in dysproteinemias

1 reference

12 December 2020

Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital

1 reference

12 December 2020

Circulating heparin-like anticoagulants: report of five consecutive cases and a review

1 reference

12 December 2020

Idiopathic thrombocytopenic purpura in lymphoma

1 reference

12 December 2020

Coagulation abnormalities in malignancy: a review

1 reference

12 December 2020

Thrombotic microangiopathies associated with drugs and bone marrow transplantation

1 reference

12 December 2020

Prevention of post-operative deep leg vein thrombosis in patients with cancer

1 reference

12 December 2020

Clinical presentation of heparin-induced thrombocytopenia.

1 reference

12 December 2020

Factor XIII-activity and fibrin subunit structure in acute leukemia

1 reference

12 December 2020

Circulating heparan sulfate proteoglycan anticoagulant from a patient with a plasma cell disorder

1 reference

12 December 2020

The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer.

1 reference

12 December 2020

Hemostasis in malignancy

1 reference

12 December 2020

Cancer- and drug-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.

1 reference

12 December 2020

Hemostatic alterations in cancer patients

1 reference

12 December 2020

DDAVP in acquired von Willebrand syndrome associated with multiple myeloma

1 reference

12 December 2020

Coagulation disorders in cancer. 3. Fibrinolysis and inhibitors

1 reference

12 December 2020

Thrombin generation in acute promyelocytic leukemia

1 reference

12 December 2020

Immune thrombocytopenia in lymphoproliferative diseases

1 reference

12 December 2020

Spontaneous resolution of acquired factor X deficiency in amyloidosis

1 reference

12 December 2020

Coagulation disorders in cancer.I. Clinical and laboratory studies

1 reference

12 December 2020

Factor X deficiency in primary amyloidosis: resolution after splenectomy

1 reference

12 December 2020

Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis.

1 reference

12 December 2020

Treatment of amyloidosis associated factor X deficiency

1 reference

12 December 2020

Hemostatic abnormalities associated with dysproteinemias

1 reference

12 December 2020

Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features

1 reference

12 December 2020

Comparison of 125I-fibrinogen kinetics and fibrinopeptide A in patients with disseminated neoplasias

1 reference

12 December 2020

Protein C and S levels in acute leukemia

1 reference

12 December 2020

A new coagulation defect associated with a case of melanomatosis

1 reference

12 December 2020

Factor V deficiency in Philadelphia-positive chronic myelogenous leukemia

1 reference

12 December 2020

Acquired von Willebrand disease in Wilms' tumor patients

1 reference

12 December 2020

Circulating Heparan Sulfate Anticoagulant in a Patient with a Fatal Bleeding Disorder

1 reference

12 December 2020

Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial

1 reference

12 December 2020

Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma

1 reference

12 December 2020

THROMBOCYTOSIS ASSOCIATED WITH MALIGNANT DISEASE

1 reference

12 December 2020

Abnormalities of blood coagulation tests in patients with cancer

1 reference

12 December 2020

A syndrome resembling idiopathic thrombocytopenic purpura in 10 patients with diverse forms of cancer

1 reference

12 December 2020

Venous thromboembolism in malignancy

1 reference

12 December 2020

Antithrombin III profiles in malignancy, relationship primary tumors and metastatic sites

1 reference

12 December 2020

Platelet Utilization in a University Hospital

1 reference

12 December 2020

A case of IgM antibodies which inhibit the contact activation of blood coagulation

1 reference

12 December 2020

Bleeding and thrombosis in the myeloproliferative disorders

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02981931

1 reference

Dimensions Publication ID

25 July 2017

1014420516

0 references

1 reference